276 related articles for article (PubMed ID: 10820524)
41. Screening based on papillomavirus detection: too many false alarms.
Prescrire Int; 2010 Aug; 19(108):178-9. PubMed ID: 20939456
[TBL] [Abstract][Full Text] [Related]
42. HPV testing in primary screening of older women.
Cuzick J; Beverley E; Ho L; Terry G; Sapper H; Mielzynska I; Lorincz A; Chan WK; Krausz T; Soutter P
Br J Cancer; 1999 Oct; 81(3):554-8. PubMed ID: 10507785
[TBL] [Abstract][Full Text] [Related]
43. Screening for cervical cancer in high-risk populations: DNA pap test or Hybrid Capture II test alone?
Miranda Pereira SM; Castelo A; Makabe S; Utagawa ML; Di Loreto C; Sakamoto Maeda MY; Marques JA; Santoro CL; Filho AL; Das Dores GB
Int J Gynecol Pathol; 2006 Jan; 25(1):38-41. PubMed ID: 16306782
[TBL] [Abstract][Full Text] [Related]
44. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
45. Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia.
Schiffman MH; Schatzkin A
Cancer Res; 1994 Apr; 54(7 Suppl):1944s-1947s. PubMed ID: 7794294
[TBL] [Abstract][Full Text] [Related]
46. Detection of cervical precancer and cancer in a hospital population; benefits of testing for human papillomavirus.
Dalstein V; Riethmuller D; Sautière JL; Prétet JL; Kantelip B; Schaal JP; Mougin C
Eur J Cancer; 2004 May; 40(8):1225-32. PubMed ID: 15110887
[TBL] [Abstract][Full Text] [Related]
47. Is it time to introduce HPV self-sampling for primary cervical cancer screening?
Petignat P; Vassilakos P
J Natl Cancer Inst; 2012 Feb; 104(3):166-7. PubMed ID: 22271766
[No Abstract] [Full Text] [Related]
48. HPV test shows low sensitivity of Pap screen in older women.
Gyllensten U; Lindell M; Gustafsson I; Wilander E
Lancet Oncol; 2010 Jun; 11(6):509-10; author reply 510-1. PubMed ID: 20522375
[No Abstract] [Full Text] [Related]
49. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women.
Clavel C; Masure M; Bory JP; Putaud I; Mangeonjean C; Lorenzato M; Nazeyrollas P; Gabriel R; Quereux C; Birembaut P
Br J Cancer; 2001 Jun; 84(12):1616-23. PubMed ID: 11401314
[TBL] [Abstract][Full Text] [Related]
50. Extended duration of the detectable stage by adding HPV test in cervical cancer screening.
van den Akker-van Marie ME; van Ballegooijen M; Rozendaal L; Meijer CJ; Habbema JD
Br J Cancer; 2003 Nov; 89(10):1830-3. PubMed ID: 14612887
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Johansson B; Forslund O; Hansson BG; Rylander E; Dillner J
N Engl J Med; 2007 Oct; 357(16):1589-97. PubMed ID: 17942872
[TBL] [Abstract][Full Text] [Related]
52. Preventing cervical cancer globally by acting locally: if not now, when?
Gage JC; Castle PE
J Natl Cancer Inst; 2010 Oct; 102(20):1524-7. PubMed ID: 20884892
[No Abstract] [Full Text] [Related]
53. Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.
El-Zein M; Richardson L; Franco EL
J Clin Virol; 2016 Mar; 76 Suppl 1(Suppl 1):S62-S68. PubMed ID: 26631958
[TBL] [Abstract][Full Text] [Related]
54. Can papilloma virus testing be used to improve cervical cancer screening?
Jenkins D; Sherlaw-Johnson C; Gallivan S
Int J Cancer; 1996 Mar; 65(6):768-73. PubMed ID: 8631589
[TBL] [Abstract][Full Text] [Related]
55. Screening for cervical cancer.
Wright TC; Goldie SJ; Cain JM; Howett MK
Science; 2000 Dec; 290(5497):1651. PubMed ID: 11186376
[No Abstract] [Full Text] [Related]
56. The difference in sensitivity between HPV testing and cytology for detecting current and future CIN2+ increases over time.
Sasieni P
Evid Based Med; 2014 Oct; 19(5):184. PubMed ID: 24785468
[No Abstract] [Full Text] [Related]
57. HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study.
Kelly RS; Patnick J; Kitchener HC; Moss SM;
Br J Cancer; 2011 Sep; 105(7):983-8. PubMed ID: 21897395
[TBL] [Abstract][Full Text] [Related]
58. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.
Nobbenhuis MA; Helmerhorst TJ; van den Brule AJ; Rozendaal L; Jaspars LH; Voorhorst FJ; Verheijen RH; Meijer CJ
J Clin Pathol; 2002 Jun; 55(6):435-9. PubMed ID: 12037026
[TBL] [Abstract][Full Text] [Related]
59. A population-based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intraepithelial neoplasia.
Kjellberg L; Wiklund F; Sjöberg I; Wadell G; Angström T; Dillner J; Mählck CG
Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1497-502. PubMed ID: 9855587
[TBL] [Abstract][Full Text] [Related]
60. HPV testing. Visible expectations and hidden realities.
Federschneider JM; Crum CP
Am J Clin Pathol; 2003 Oct; 120(4):483-4. PubMed ID: 14560559
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
